Ivan Chong Hon Kuan
Direttore/Membro del Consiglio presso Rockeby Biomed Ltd.
Profilo
Ivan Chong Hon Kuan is currently an Executive Director at Rockeby Biomed Ltd.
He previously worked as a Non-Executive Director at the same company from 2008 to 2009.
Posizioni attive di Ivan Chong Hon Kuan
| Società | Posizione | Inizio |
|---|---|---|
Rockeby Biomed Ltd.
 Rockeby Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Rockeby Biomed Ltd. provides research, development and marketing of rapid testing technologies for infectious diseases in animals and humans. The company's main market is in-vitro diagnostic testing which includes serology testing in hospitals as well as point of care rapid tests for use by healthcare professionals and consumers inside and outside of traditional healthcare environments. The company is headquartered in West Perth, Australia. | Direttore/Membro del Consiglio | 04/11/2009 |
Precedenti posizioni note di Ivan Chong Hon Kuan
| Società | Posizione | Fine |
|---|---|---|
Rockeby Biomed Ltd.
Rockeby Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Rockeby Biomed Ltd. provides research, development and marketing of rapid testing technologies for infectious diseases in animals and humans. The company's main market is in-vitro diagnostic testing which includes serology testing in hospitals as well as point of care rapid tests for use by healthcare professionals and consumers inside and outside of traditional healthcare environments. The company is headquartered in West Perth, Australia. | Direttore/Membro del Consiglio | 20/04/2009 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Rockeby Biomed Ltd.
Rockeby Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Rockeby Biomed Ltd. provides research, development and marketing of rapid testing technologies for infectious diseases in animals and humans. The company's main market is in-vitro diagnostic testing which includes serology testing in hospitals as well as point of care rapid tests for use by healthcare professionals and consumers inside and outside of traditional healthcare environments. The company is headquartered in West Perth, Australia. | Commercial Services |
- Borsa valori
- Insiders
- Ivan Chong Hon Kuan
